By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Par Pharmaceutical, Inc. 

One Ram Ridge Road

Spring Valley  New York  10977  U.S.A.
Phone: 800-727-0923 Fax: 845-425-7167



Company News
IntelliPharmaCeutics Reports On Launch Of Additional Strengths Of Generic Focalin XR By Par Pharma 1/6/2017 8:05:01 AM
Endo International (ENDP) Announces Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Par Pharma 9/25/2015 11:55:35 AM
Par Pharma Begins Shipment Of Generic AndroGel 1% 9/2/2015 7:56:59 AM
Par Pharma Begins Shipment Of Generic Megace ES 7/29/2015 11:40:37 AM
Endo Pharmaceuticals (ENDP) Continues Expansion With $8.05 Billion Acquisition of Par Pharma 5/18/2015 6:05:19 AM
PE Firm-Owned Par Pharma Files for $100 Million IPO 3/13/2015 6:22:04 AM
Par Pharmaceutical, Inc. Announces Fourth-Quarter And Full-Year 2014 Conference Call 3/6/2015 7:25:21 AM
Sucampo Pharmaceuticals, Inc. (SCMP) Announces Resolution Of Par Pharmaceutical, Inc.'s ANDA For RESCULA 2/12/2015 7:18:10 AM
Par Pharmaceutical, Inc. Announces First FDA Approval Of Vasostrict™ (Vasopressin Injection, USP) 11/12/2014 7:23:49 AM
Par Pharmaceutical, Inc. Announces Quarterly Conference Call 11/6/2014 9:02:03 AM